# Identification of Clopidogrel CYP2C19 Metabolizer and Thienopyridine Treatment After an Acute Coronary Syndrome

> **NCT01390974** · — · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 270 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01390974
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2014-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01390974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01390974, "Identification of Clopidogrel CYP2C19 Metabolizer and Thienopyridine Treatment After an Acute Coronary Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01390974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*